Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: Food and Drug Administration Last Updated: Nov 29, 2012 - 7:11:02 AM



FDA Cautions on Accurate Vitamin D Supplementation for Infants

By Food and Drug Administration
Jun 16, 2010 - 11:02:14 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
(HealthNewsDigest.com) - The Food and Drug Administration alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants.

The FDA also advised manufacturers of liquid Vitamin D supplements that droppers accompanying these products should be clearly and accurately marked for 400 international units (IU). In addition, for products intended for infants, FDA recommends that the dropper hold no more than 400 IU.

The American Academy of Pediatrics (AAP) has recommended a dose of 400 IU of Vitamin D supplement per day to breast-fed and partially breast-fed infants. The easiest way to ensure that an infant will not get more than the recommended dose is to use a product supplied with a dropper that will give no more than 400 IU per dose. The AAP’s recommendations are provided in the attached link.
http://aapnews.aappublications.org/cgi/content/full/aapnews.20100428-1v1

Excessive amounts of Vitamin D can be harmful to infants, and may be characterized by nausea and vomiting, loss of appetite, excessive thirst, frequent urination, constipation, abdominal pain, muscle weakness, muscle and joint aches, confusion, and fatigue, as well as more serious consequences such as kidney damage.


Consumer Article: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm214343.htm

MedWatch Alert: http://wcms.fda.gov/FDAgov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm215523.htm

Letter to Industry: http://www.fda.gov/Food/DietarySupplements/GuidanceComplianceRegulatoryInformation/default.htm

Subscribe to our FREE Ezine and receive current Health News, be eligible for discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com

For advertising or promotion, email: [email protected]


Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines


+ Harnessing the Power of Databases to Evaluate Medical Products
+ FDA Approves Drug-Free Treatment CEFALY® for Migraine Prevention
+ FDA Opens Review of Rules for Over-the-Counter Drugs, Including Acetaminophen
+ Novel New Drug Approvals
+ Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX® for the Treatment of Peyronie's Disease
+ FDA Takes Two Important Actions on Drug Shortages
+ FDA Approves New Drug to Treat Major Depressive Disorder
+ FDA Teams Prepare for Biological Threats
+ FDA Finalizes New System to Identify Medical Devices
+ FDA Warns of Rare Acetaminophen Risk



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions